Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA-PDT for Moderate to Severe Acne Vulgaris
NCT04018885Phase 2Completed
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Start
- Jul 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aminolevulinic acid 10% gel in acne vulgaris, sponsored by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.. Started Jul 2019; status: completed.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04018885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04018885.